Evaluation of Effectiveness of Two Different Doses of Mivacurium in Rapid Sequence Intubation
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
Mivacurium can be considered as an optimal choice for muscle relaxation in short duration
surgeries, as butyrylcholinesterase can rapidly and reliably degrade this benzylisoquinoline
muscle relaxant in vivo. However the histamine release related to a rapid high-dose
injection, unsatisfactory intubation conditions and unexpected delay in recovery in patients
may be encountered with butyrylcholinesterase deficiency